What is Proteintech Group?
Proteintech Group is a prominent supplier of high-quality antibodies, ELISA kits, and proteins, crucial for advancing research accuracy and reproducibility across various scientific disciplines. The company's extensive product catalog supports a wide array of applications, including Western Blot, immunohistochemistry, and flow cytometry, serving researchers in genomics, cancer, immunology, and neuroscience. Beyond its product offerings, Proteintech Group also provides custom services designed to enhance the capabilities of its research clientele.
How much funding has Proteintech Group raised?
Proteintech Group has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Proteintech Group?
The substantial late-stage funding and strategic investment indicate Proteintech Group is poised for significant growth and potential market consolidation. This capital infusion is likely to fuel further product development, expansion of manufacturing capabilities, and broader market penetration. The company's focus on foundational research tools suggests a strategy aimed at becoming an indispensable partner for academic and industrial researchers globally, reinforcing its role in accelerating scientific discovery.
See full Proteintech Group company page
